International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2021 - Volume 25, Number 4
View All Articles in Issue

Page(s): 327

Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, nifedipine, oral suspension, Prinzmetal variant angina, chronic stable angina pectoris, chest pain, hypertension, high blood pressure, Raynaud phenomenon, preterm labor, acute myocardial infarction, heart attack, cardiac disorders, heart disease

Related Categories: FORMULATIONS, CARDIOLOGY, DOSAGE FORMS/DRUG CARRIERS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jul/Aug 2021 Pg. 327
Basics of Compounding for Raynaud's Disease Glasnapp Andrew	Jul/Aug 2003 Pg. 288-291
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2018 Pg. 233
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored Allen Loyd V Jr	Mar/Apr 2022 Pg. 146
Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 147
Featured Excipient: Flavor Enhancing Agents Allen Loyd V Jr	Jan/Feb 2003 Pg. 48-50
Nifedipine 10-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 423
Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jan/Feb 2020 Pg. 54
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 493
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Nifedipine 4-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2006 Pg. 303
Nifedipine 1-mg/500-mg Oral Powder Allen Loyd V Jr	Sep/Oct 2011 Pg. 422
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline Riepl Mike	Jul/Aug 2022 Pg. 270-274
Compounding for the Treatment of COVID-19 and Long COVID, Part 1: Terminology, Mutations, and Variants Riepl Mike	Jan/Feb 2023 Pg. 12-21
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Allen Loyd V Jr	Nov/Dec 2019 Pg. 487
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF Allen Loyd V Jr	Nov/Dec 2019 Pg. 494
Return to Top